User menu

Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups

Bibliographic reference de Witte, T. ; Hagemeijer, Anne ; Suciu, Stefan ; Belhabri, A ; Delforge, Michel ; et. al. Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups.32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group (Hamburg (Germany), Mar 19-22, 2006). In: Bone Marrow Transplantation, Vol. 37, p. S1-S1 (2006)
Permanent URL http://hdl.handle.net/2078.1/60044